54840 Federal Register / Vol. 73, No. 185 / Tuesday, September 23, 2008 / Notices 

Norwalk, Connecticut, Court of Federal 

Claims Number 07–0890V. 

302. Roger Feldman, Weston, 

Massachusetts, Court of Federal Claims 

Number 07–0891V. 

303. Elisabeth and Bernard Hil 

Bowman on behalf of Kaylin Bowman, 

Dallas, Texas, Court of Federal Claims 

Number 07–0892V. 

304. Tieu Binh Le, Monahans, Texas, 

Court of Federal Claims Number 07– 

0895V. 

Dated: September 12, 2008. 

Elizabeth M. Duke, 

Administrator. 

[FR Doc. E8–22129 Filed 9–22–08; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Submission for Proposed Collection 

Comment Request: The Effectiveness 

of the NIH Curriculum Supplements 

Programs 

SUMMARY: In compliance with the 

requirements of section 3506(c)(2)(A) of 

the Paperwork Reduction Act of 1995, 

for opportunity for public comment on 

proposed data collection projects, the 

Office of Science Education, the 

National Institutes of Health (NIH) will 

publish periodic summaries of proposed 

projects to be submitted to the Office of 

Management and Budget (OMB) for 

review and approval. 

Proposed Collection Title: The 

Effectiveness of the NIH Curriculum 

Supplements Programs Survey. 

Information Collection Request: New. 

Need and Use of Information 

Collection: The survey will attempt to 

assess customer demographics and their 

satisfaction with the NIH curriculum 

supplements in presenting science in a 

more engaging and interactive way. The 

supplements help K–12 educators teach 

science by featuring the latest NIH 

research and utilized research-based 

instructional methods. A typical 

supplement contains two weeks of 

student activities on the science behind 

a health topic, such as cancer, sleep or 

obesity. Web-based simulations, 

animations and experiments enhance 

the ‘‘pencil and paper’’ activities. In 

addition to developing and distributing 

the supplements, OSE conducts 

professional workshops to help teachers 

successfully implement these lessons 

with their students. Since January 2000, 

over 6,000 teachers have attended an 

OSE workshop. Assessing the 

effectiveness of the NIH curriculum 

supplements and teacher workshops is 

critical to determining if OSE is 

successfully fulfilling its mission. OSE 

has the database infrastructure in place 

to easily collect data from supplement 

requesters and workshop attendees. At 

present, we do not have clearance to 

contact our customers to determine how 

NIH resources are meeting their 

educational needs. 

BURDEN TABLE

Type of respondent: survey title Number of respondents 

Frequency of 

response 

Average time 

per response 

(hours) 

Hour burden 

per year 

(hours) 

Supplement requestor ..................................................................................... 16,000 1 0 .17 910 

Workshop Teacher: initial survey .................................................................... 2,000 1 0 .17 117 

Workshop Teacher: in-depth survey ................................................................ 200 1 0 .5 34 

Totals ........................................................................................................ 18,200 n/a n/a 1,061 

Request for Comments: Written 

comments and/or suggestions from the 

public and affected agencies are invited 

on one or more of the following points: 

(1) Whether the proposed collection of 

information is necessary for the proper 

performance of the function of the 

agency, including whether the 

information will have practical utility; 

(2) ways to enhance the quality, utility, 

and clarity of the information to be 

collected; and (3) ways to minimize the 

burden of the collection of information 

on those who are to respond, including 

the use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology. 

Direct Comments to NIH: Written 

comments and/or suggestions regarding 

the item(s) contained in this notice 

should be directed to the: Office of 

Science Education, National Institutes 

of Health, 6100 Executive Boulevard, 

Suite 3E01, Bethesda, MD 20892, 

Attention: Dr. Dave Vannier. To request 

more information on the proposed 

project or to obtain a copy of the data 

collection plans and survey, contact: Dr. 

Vannier at the above address, or call 

301–496–8741, or e-mail your request 

including your address to: 

vannierd@od.nih.gov. 

Comments Due Date: Comments 

regarding this information collection are 

best assured of having their full effect if 

received within 60 days of the date of 

this publication. 

Dated: September 16, 2008. 

David Vannier, 

Office of Science Education, National 

Institutes of Health. 

[FR Doc. E8–22315 Filed 9–22–08; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Neurological 

Disorders and Stroke; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the 

Board of Scientific Counselors, National 

Institute of Neurological Disorders and 

Stroke. 

The meeting will be closed to the 

public as indicated below in accordance 

with the provisions set forth in section 

552b(c)(6), Title 5 U.S.C., as amended 

for the review, discussion, and 

evaluation of individual intramural 

programs and projects conducted by the 

National Institute of Neurological 

Disorders and Stroke, including 

consideration of personnel 

qualifications and performance, and the 


jlentini on PROD1PC65 with NOTICES
Federal Register / Vol. 73, No. 185 / Tuesday, September 23, 2008 / Notices 54841 

competence of individual investigators, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Board of Scientific 

Counselors, National Institute of 

Neurological Disorders and Stroke. 

Date: October 5–7, 2008. 

Time: October 5, 2008, 7 p.m. to 10 p.m. 

Agenda: To review and evaluate personal 

qualifications and performance, and 

competence of individual investigators. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Diplomat/Ambassador Room, 

Bethesda, MD 20814. 

Time: October 6, 2008, 8:30 a.m. to 2:10 

p.m. 

Agenda: To review and evaluate personal 

qualifications and performance, and 

competence of individual investigators. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Conference Room A, Rockville, 

MD 20852. 

Time: October 6, 2008, 3:10 p.m. to 8:10 

p.m. 

Agenda: To review and evaluate personal 

qualifications and performance, and 

competence of individual investigators. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Diplomat/Ambassador Room, 

Bethesda, MD 20814. 

Time: October 7, 2008, 8:30 a.m. to 12 p.m. 

Agenda: To review and evaluate personal 

qualifications and performance, and 

competence of individual investigators. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Diplomat/Ambassador Room, 

Bethesda, MD 20814. 

Contact Person: Alan P. Koretsky, PhD, 

Scientific Director, Division of Intramural 

Research, National Institute of Neurological 

Disorders & Stroke, NIH, 35 Convent Drive, 

Room 6a 908, Bethesda, MD 20892, 301–435– 

2232, koretskya@ninds.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.853, Clinical Research 

Related to Neurological Disorders; 93.854, 

Biological Basis Research in the 

Neurosciences, National Institutes of Health, 

HHS) 

Dated: September 17, 2008. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E8–22309 Filed 9–22–08; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2) notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 552b(c) 

(4) and 552b(c) (6), Title 5 U.S.C., as 

amended. The purpose of this meeting 

is to evaluate requests for preclinical 

development resources for potential 

new therapeutics for the treatment of 

cancer. The outcome of the evaluation 

will be a decision whether NCI should 

support request(s) and make available 

contract resources for development of 

the potential therapeutic to improve the 

treatment of various forms of cancer. 

The research proposals and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material and 

personal information concerning 

individuals associated with the 

proposed research projects, the 

disclosure of which would constitute a 

clearly unwarranted invasion of 

personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Rapid 

Access to Intervention Development. 

Date: November 5–6, 2008. 

Time: 1 p.m.–5 p.m. 

Agenda: To evaluate the Rapid Access to 

Intervention Development Portfolio. 

Place: National Institutes of Health, 

Executive Plaza North, Conference Room H, 

6130 Executive Boulevard, Rockville, MD 

20852. 

Contact Person: Phyllis G. Bryant, 

Executive Secretary, Program Analyst, 

Developmental Therapeutics Program, 

National Cancer Institute, NIH, 6130 

Executive Boulevard, Rm. 8022, Bethesda, 

MD 20892, (301) 496–8720, pb45q@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: September 17, 2008. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E8–22316 Filed 9–22–08; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Initial Review Group; Neuroscience of 

Aging Review Committee. 

Date: October 14–15, 2008. 

Time: 4 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Doubletree Hotel Bethesda, 8120 

Wisconsin Avenue, Bethesda, MD 20814. 

Contact Person: William Cruce, PhD, 

Scientific Review Administrator, National 

Institute on Aging, Scientific Review Office, 

Gateway Building 2C–212, 7201 Wisconsin 

Ave., Bethesda, MD 20814, 301–402–7704, 

crucew@nia.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program No. 93.866, Aging Research, 

National Institutes of Health, HHS) 

Dated: September 15, 2008. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E8–22057 Filed 9–22–08; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of the Director, National 

Institutes of Health; Office of 

Biotechnology Activity; Recombinant 

DNA Research; Notice of a Meeting of 

an NIH Blue Ribbon Panel 

There will be a meeting of the NIH 

Blue Ribbon Panel to advise on the Risk 

Assessment of the National Emerging 

Infectious Diseases Laboratories 

(NEIDL). The meeting will be held on 

Tuesday, October 14, 2008, at the 

Roxbury Center for the Arts, Hibernian 

Hall, 184 Dudley Street, Roxbury, MA 


jlentini on PROD1PC65 with NOTICES